Seeking Alpha

Momenta Pharmaceuticals (MNTA -3.7%) slides after reporting a wider than expected Q1 loss this...

Momenta Pharmaceuticals (MNTA -3.7%) slides after reporting a wider than expected Q1 loss this morning. The company attributes the miss to the January 2012 launch of a competitor's generic Lovenox, causing decreased unit sales and lower market share, which in turn led to lower prices in response to competitor pricing reductions.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|